News

The company said that the combination reduces the accumulation of retained species on the membrane surface, which allows for increased transmission of the target molecule. The PallSep Biotech

The proposed transaction will take place pursuant to Section 363 of the US Bankruptcy Code and will be governed by a court-directed bidding process, subject to applicable regulatory,

A total of 401 patients participated in the 12-week, double-blind, placebo-controlled study, designed to assess the efficacy of duloxetine 60mg once daily on the reduction of pain severity

Auxilium has established a distribution network that will allow health care providers to access Xiaflex through specialty distributors and specialty pharmacies or in the institutional setting after they

The company said that its scientists are currently presenting the validation results of the SmartChip Real-Time PCR System at the Cambridge Healthcare Institute’s 17th International Molecular Medicine Tri-Conference.

As per the agreement, the total milestone payments could reach GBP207m in the event of launch in multiple indications. Apeiron will receive an up-front payment of GBP11m in

Since 2005, TaconicArtemis, a German subsidiary of Taconic, has been working with its Scottish partner, CXR Biosciences (Dundee, Scotland) to deliver new, commercially viable, models that are more

The company said that the approval was based on the clinical studies which showed that the addition of lidocaine to Restylane and Perlane reduced pain experienced by patients,

The company said that the patent, which will remain in force until 2028, covers a new Repligen proprietary product which is now available in commercial quantities. The product